Patients with primary progressive MS more commonly exhibited delays in overall disability progression following treatment with ocrelizumab vs placebo.

As they explained in their case report in the Journal of Neurology and Neuroscience, ophthalmologic examination identified ...

The 2024 McDonald criteria, published just before the 2025 ECTRIMS Congress, substantially expand criteria for a probable diagnosis of multiple sclerosis, experts report.

The new H-1B fee will “hurt the innovation and competitiveness of the U.S. industry,” says Subodha Kumar, a professor at the ...

In February 2025, SAP & Databricks announced a landmark partnership to offer SAP Databricks, a natively integrated data + AI ...

Goldman Sachs is well-positioned to benefit from anticipated Fed rate cuts, fueling M&A, IPOs, and trading activity growth.

Discover how ClickUp and Monday.com enhance project management with integrations, automation, and collaboration. Compare ...

Recent advances in high-throughput microbiome profiling have generated expansive data sets that offer unprecedented ...

With clear governance, thoughtful setup and a user-first approach, organizations can unlock the full value of their ...

Rocket Lab posted strong Q2 growth with rising margins, a $1B backlog, and solid liquidity to support Neutron and NSSL ...

Driven by our mission to make data and AI accessible, inclusive, and actionable, DataGlobal Hub curated a world-class agenda ...

Switzerland has set itself the goal of reducing its CO₂ emissions to net-zero by 2050. The final report of the POLIZERO research project—led by the Paul Scherrer Institute PSI and the University of ...